Although nintedanib treatment resulted in lung functional improvement to a similar extent in both young (49%) and aged (57%) mice (figure 1h), results did not reach statistical significance in aged mice.
← all excerpts
Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing.
1
—
—